Ozempic and other weight-loss-related drugs have taken the nation by storm. The Danish company that manufactures Ozempic, Novo Nordisk, has made nearly $50 billion on the sales of Ozempic and Wegovy since 2018. The U.S. has been described as a "cash cow" for the company, accounting for 72% of their worldwide sales of those two drugs.

This still life series is inspired by the novelty and artificial nature of the drug, and trying to understand how it fits into our overall wellbeing and relationship with our bodies.